EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antithrombotic effect and plasma pharmacochemistry of Justicia Procumbens L

Hui Zhang, Yating Liu, Fengxian Hu, Siyi Chen, Zhoutao Xie, Hezhen Wu, Ting Zhang, Bo Liu iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0321023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Hui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: Plant Extracts, Justicia, Fibrinolytic Agents, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Knowledge Innovation Program of Wuhan -Basic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Justicia procumbens L. contains lignans with remarkable antiplatelet aggregation effects. Its ethyl acetate extract has demonstrated the efficacy of inhibiting platelet aggregation in preliminary tests. Identifying key components, elucidating the antithrombotic mechanism, and evaluating its potential for treating thrombotic diseases are of great significance.

Methods

Chemical analysis was conducted on the ethyl acetate extract of J. procumbens . Animal models of carotid artery and venous thrombosis, combined with proteomics analysis, were employed to study the antithrombotic mechanism.

Results

Chemical analysis identified justicidin B (JB) and chinensinaphthol methyl ether (CME) as the major active antithrombotic constituents. The extract inhibited platelet aggregation by regulating relevant signaling pathways, showing potential in preventing both venous and arterial thrombosis.

Conclusions

This study confirmed that the ethyl acetate extract of J. procumbens , especially the lignan components JB and CME, can effectively inhibit platelet aggregation, showing promising prospects in treating thrombotic diseases. This provides ideas for the development of health products based on J. procumbens and lays a foundation for further clinical exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsJusticiaFibrinolytic AgentsPlatelet Aggregation InhibitorsThrombosisAnimalsPlatelet AggregationMaleLignansDisease Models, Animal

Substanzen

Plant ExtractsFibrinolytic AgentsPlatelet Aggregation InhibitorsLignans

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
  • Key Laboratory of Traditional Chinese Medicine Resources and Chemistry of Hubei Province, Wuhan, China.
  • Hubei Provincial Hospital of Integrated Chinese & Western Medicine, Wuhan, China.
  • Modern Engineering Research Center of Traditional Chinese Medicine and Ethnic Medicine of Hubei Province, Wuhan, China.
  • Hubei Shizhen Laboratory, Wuhan, China.
  • Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.

ORCID-Profile: Bo Liu

Förderung

  • Knowledge Innovation Program of Wuhan -Basic Research

Zitieren

APA

Zhang, H., Liu, Y., Hu, F., Chen, S., Xie, Z., Wu, H., Zhang, T., & Liu, B. (2025). Antithrombotic effect and plasma pharmacochemistry of Justicia Procumbens L. PLOS One. https://doi.org/10.1371/journal.pone.0321023

Vancouver

Zhang H, Liu Y, Hu F, Chen S, Xie Z, Wu H, et al. Antithrombotic effect and plasma pharmacochemistry of Justicia Procumbens L. PLOS One. 2025. doi:10.1371/journal.pone.0321023

BibTeX
@article{Zhang2025,
  author = {Zhang, Hui and Liu, Yating and Hu, Fengxian and Chen, Siyi and Xie, Zhoutao and Wu, Hezhen and Zhang, Ting and Liu, Bo},
  title = {Antithrombotic effect and plasma pharmacochemistry of Justicia Procumbens L},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321023}
}
Kostenlos starten →